van Houte Hans (CIK 1817217) reported 37 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-04). Recent activity: Sell NRIX (1,794 shares), Sell NRIX (2,967 shares), Buy NRIX (3,750 shares), Buy NRIX (2,858 shares), Buy NRIX (3,572 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-04 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Sell | 1,794 | $42,861 |
| 2026-08-04 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Sell | 2,967 | $73,129 |
| 2026-07-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Buy | 3,750 | $0 |
| 2026-07-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Buy | 2,858 | $0 |
| 2026-07-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Buy | 3,572 | $0 |
| 2026-07-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Sell | 2,845 | $66,524 |
| 2026-05-05 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Sell | 13,473 | $223,323 |
| 2026-05-05 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Sell | 582 | $9,996 |
| 2026-04-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Buy | 2,000 | $0 |
| 2026-04-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Buy | 3,750 | $0 |
| 2026-04-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Buy | 2,858 | $0 |
| 2026-04-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Sell | 2,388 | $39,749 |
| 2026-01-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Buy | 2,887 | $0 |
| 2026-01-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Buy | 2,000 | $0 |
| 2026-01-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Buy | 3,750 | $0 |
| 2026-01-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Buy | 2,859 | $0 |
| 2026-01-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Sell | 3,588 | $59,489 |
| 2026-01-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Sell | 73 | $1,268 |
| 2025-11-03 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Sell | 6,284 | $78,927 |
| 2025-10-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Buy | 2,886 | $0 |
| 2025-10-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Buy | 2,000 | $0 |
| 2025-10-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Buy | 3,750 | $0 |
| 2025-10-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Buy | 2,858 | $0 |
| 2025-10-30 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Sell | 3,130 | $40,064 |
| 2025-08-01 | Nurix Therapeutics, Inc. (NRIX) | Chief Financial Officer | Sell | 5,402 | $59,584 |
Source: SEC Form 4 filings · as of 2026-08-04